Showing results (2401-2410 of 2,890) with videos related to
Sort By:
Pageof 289
Forensic Science International|December 22, 2009
The application of computerized tomography (CT) to the dental ageing of children and adolescentsJ P Graham, C J O'Donnell, P J G Craig, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsCaitlin S Latimer, Rod L Walker, Marika Bogdani, et al.Dermatologic Clinics|November 21, 2022
Merkel Cell CarcinomaDaniel J Lewis, Joseph F Sobanko, Jeremy R Etzkorn, et al.The European Journal of Neuroscience|July 31, 2003
The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in miceP Sinnayah, J R Blair-West, M I McBurnie, et al.Plos Neglected Tropical Diseases|May 3, 2011
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairmentStephen L Walker, Peter G Nicholls, Sushmita Dhakal, et al.Plos One|January 13, 2012
Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafishSteven L Walker, Junko Ariga, Jonathan R Mathias, et al.Gynecologic Oncology|December 3, 2005
Preoperative predictors of positive margins after loop electrosurgical excisional procedure-ConeTodd D Tillmanns, Camille A Falkner, David B Engle, et al.Journal of Computer Assisted Tomography|January 8, 2015
Assessment of single-bolus contrast administration technique using hybrid dual-source ECG-gated thoracic and dual-source non-ECG-gated high-pitch abdominopelvic CT acquisitions for procedural planning before transcatheter aortic valve replacementWendy L Walker, Daniel T Boll, Juliana M Bueno, et al.Leprosy Review|September 25, 2012
A comparison of the change in clinical severity scale score and a retrospective physician assessment of neurological outcome in individuals with leprosy associated nerve function impairment after treatment with corticosteroidsStephen L Walker, Peter G Nicholls, Sushmita Dhakal, et al.Gynecologic Oncology|February 1, 2011
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group studyMark A Morgan, Michael W Sill, Keiichi Fujiwara, et al.Pageof 289